Investing Profile

Amir Nashat

VCInvestor
Managing Partner at Polaris Partners
polarispartners.com/partner/a...Cambridge, Massachusetts
Photo of Amir Nashat, Managing Partner at Polaris Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Polaris Partners Managing Partner
$300K - $2.0M
$500K
58
$4B
CompanyStageDateRound SizeTotal Raised
Matter Neuroscience
SeedFeb 2024$26M
$26M
Co-investors: Paul Berns (ARCH Venture Partners)
Freenome
Series UnknownFeb 2024$250M
Series DDec 2021$300M
Series CAug 2020$270M
Series BJul 2019$160M
Series AAug 2017$7M
Series AMar 2017$65M
$1.1B
Co-investors: Daniel Coley (Cofounders Capital), Peter Kolchinsky (RA Capital), Jeffrey Schwartz (Bain Capital Life Sciences), Bill Maris (Section 32), Vasudev Bailey (Artis Ventures (AV)), Skip Fleshman (Asset Management Ventures), Anne Wojcicki
Jnana Therapeutics
Series CNov 2022$110M
Series ADec 2017$50M
$160M
Co-investors: Kevin Kinsella (Avalon Ventures), Carlo Rizzuto (Versant Ventures)
Scholar Rock
Post Ipo EquityJun 2022$210M
Series CJan 2018$47M
Series BJan 2016$36M
Series ASep 2014$20M
$310M
Co-investors: Timothy A. Springer
Dewpoint Therapeutics
Series CFeb 2022$150M
Series BSep 2020$77M
Series AJan 2019$60M
$290M
Co-investors: Kristina Burow (ARCH Venture Partners), Caleb Appleton (Bison Ventures), Vikas Parekh (SoftBank Vision Fund)
Kojin Therapeutics
Series AJun 2021$60M
$60M
Primmune Therapeutics
Series AOct 2020$27M
$27M
1366 Technologies
Series EDec 2019$18M
Series COct 2013$15M
Series BDec 2010$6M
Series BOct 2010$20M
$96M
Co-investors: Carmichael Roberts (Breakthrough Energy Ventures)